Association of NAT1 and NAT2 genes with nonsyndromic cleft lip and palate

Molecular Medicine Reports

Volumn 8, Issue 1, 2013, Pages 211-216

  Song, Tao ^a   Wu, Di ^a   Wang, Yongqian ^a   Li, Haidong ^a   Yin, Ningbei ^a   Zhao, Zhenmin ^a  

^a PLASTIC SURGERY HOSPITAL   (China)

Author keywords

Cleft lip; NAT1; NAT2

Indexed keywords

ACYLTRANSFERASE; ACYLTRANSFERASE 1; ACYLTRANSFERASE 2; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; MALE; NONSYNDROMIC CLEFT LIP AND PALATE; PRESCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CLEFT LIP; CLEFT PALATE; EPISTASIS, GENETIC; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ISOENZYMES; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84878946997     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1467     Document Type: Article

References (22)

1. Stuppia L, Capogreco M, Marzo G, et al: Genetics of syndromic and nonsyndromic cleft lip and palate. J Craniofac Surg 22: 1722-1726, 2011.
2. Munger RG, Romitti PA, Daack-Hirsch S, Burns TL, Murray JC and Hanson J: Maternal alcohol use and risk of orofacial cleft birth defects. Teratology 54: 27-33, 1996. (Pubitemid 26395136)
3. Little J, Cardy A, Arslan MT, Gilmour M and Mossey PA: Smoking and orofacial clefts: a United Kingdom-based case-control study. Cleft Palate Craniofac J 41: 381-386, 2004. (Pubitemid 38943972)
4. Jia ZL, Shi B, Chen CH, Shi JY, Wu J and Xu X: Maternal malnutrition, environmental exposure during pregnancy and the risk of non-syndromic orofacial clefts. Oral Dis 17: 584-589, 2011.
5. Hernández-Diaz S, Smith CR, Shen A, et al: Comparative safety of antiepileptic drugs during pregnancy. Neurology 78: 1692-1699, 2012.
6. Cech I, Burau KD and Walston J: Spatial distribution of orofacial cleft defect births in Harris County, Texas, 1990 to 1994, and historical evidence for the presence of low-level radioactivity in tap water. South Med J 100: 560-569, 2007.
7. Ramirez D, Lammer EJ, Iovannisci DM, Laurent C, Finnell RH and Shaw GM: Maternal smoking during early pregnancy, GSTP1 and EPHX1 variants, and risk of isolated orofacial clefts. Cleft Palate Craniofac J 44: 366-373, 2007.
8. Sim E, Fakis G, Laurieri N and Boukouvala S: Arylamine N-acetyltransferases - from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention. Adv Pharmacol 63: 169-205, 2012.
9. Mortensen HM, Froment A, Lema G, et al: Characterization of genetic variation and natural selection at the arylamine N-acetyltransferase genes in global human populations. Pharmacogenomics 12: 1545-1558, 2011.
10. Boukouvala S and Fakis G: Arylamine N-acetyltransferases: what we learn from genes and genomes. Drug Metab Rev 37: 511-564, 2005. (Pubitemid 41434161)
11. Smelt VA, Mardon HJ and Sim E: Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2. Pharmacol Toxicol 83: 149-157, 1998. (Pubitemid 28487623)
12. Ward A, Hickman D, Gordon JW and Sim E: Arylamine N-acetyltransferase in human red blood cells. Biochem Pharmacol 44: 1099-1104, 1992.
13. Minchin RF: Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem J 307 (Pt 1): 1-3, 1995.
14. Erickson RP, Cao W, Acuña DK, et al: Confirmation of the role of N-acetyltransferase 2 in teratogen-induced cleft palate using transgenics and knockouts. Mol Reprod Dev 75: 1071-1076, 2008. (Pubitemid 351628592)
15. Lammer EJ, Shaw GM, Iovannisci DM, Van Waes J and Finnell RH: Maternal smoking and the risk of orofacial clefts: susceptibility with NAT1 and NAT2 polymorphisms. Epidemiology 15: 150-156, 2004. (Pubitemid 40416968)
16. Lammer EJ, Shaw GM, Iovannisci DM and Finnell RH: Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts. Birth Defects Res A Clin Mol Teratol 70: 846-852, 2004. (Pubitemid 39602195)
17. Lie RT, Wilcox AJ, Taylor J, et al: Maternal smoking and oral clefts: the role of detoxification pathway genes. Epidemiology 19: 606-615, 2008.
18. Shi M, Christensen K, Weinberg CR, et al: Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants. Am J Hum Genet 80: 76-90, 2007. (Pubitemid 46047652)
19. van Rooij IA, Groenen PM, van Drongelen M, Te Morsche RH, Peters WH and Steegers-Theunissen RP: Orofacial clefts and spina bifida: N-acetyltransferase phenotype, maternal smoking, and medication use. Teratology 66: 260-266, 2002. (Pubitemid 35266243)
20. Komar AA: Silent SNPs: impact on gene function and phenotype. Pharmacogenomics 8: 1075-1080, 2007.
21. Cornish VA, Pinter K, Boukouvala S, et al: Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene. Pharmacogenomics J 3: 169-177, 2003. (Pubitemid 36850158)
22. Sugamori KS, Wong S, Gaedigk A, et al: Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice. Mol Pharmacol 64: 170-179, 2003. (Pubitemid 36759829)